KVUEKenvue Inc.

NYSE www.jnj.com/kenvue/


$ 20.45 $ 0.37 (1.84 %)    

Wednesday, 08-May-2024 15:59:56 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 20.45
$ 20.08
$ 0.00 x 0
$ 0.00 x 0
$ 20.00 - $ 20.68
$ 17.45 - $ 26.99
23,642,579
na
37.84B
$ 0.77
$ 22.74
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-01-2024 12-31-2023 10-K
2 11-03-2023 10-01-2023 10-Q
3 08-02-2023 07-02-2023 10-Q
4 06-02-2023 04-02-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hsbc-maintains-hold-on-kenvue-raises-price-target-to-21

HSBC analyst Jeremy Fialko maintains Kenvue (NYSE:KVUE) with a Hold and raises the price target from $20 to $21.

 us-stocks-eye-fourth-positive-session-despite-hawkish-fed-remarks-disney-palantir-tumble-treasury-yields-fall-whats-driving-markets-tuesday

Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data an...

 band-aid-maker-kenvue-cuts-workforce-by-4-q1-earnings-beat-street-expectations

Kenvue's first-quarter sales of $3.89 billion. Organic growth surged by 1.9% amidst strong demand in Self Care and Essentia...

 johnson--johnson-childrens-cough-syrup-contaminated-in-some-batches---who-poised-to-issue-global-alert-updated

WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detect...

 bernstein-initiates-coverage-on-kenvue-with-underperform-rating-announces-price-target-of-18

Bernstein analyst Callum Elliott initiates coverage on Kenvue (NYSE:KVUE) with a Underperform rating and announces Price Tar...

 william-blair-initiates-coverage-on-kenvue-with-market-perform-rating

William Blair analyst Jon Andersen initiates coverage on Kenvue (NYSE:KVUE) with a Market Perform rating.

 goldman-sachs-maintains-neutral-on-kenvue-lowers-price-target-to-20

Goldman Sachs analyst Bonnie Herzog maintains Kenvue (NYSE:KVUE) with a Neutral and lowers the price target from $26 to $20.

 goldman-sachs-downgrades-kenvue-to-neutral-maintains-price-target-to-20

Goldman Sachs analyst Bonnie Herzog downgrades Kenvue (NYSE:KVUE) from Buy to Neutral and maintains the price target from $2...

 rbc-capital-reiterates-outperform-on-kenvue-maintains-24-price-target

RBC Capital analyst Nik Modi reiterates Kenvue (NYSE:KVUE) with a Outperform and maintains $24 price target.

 jp-morgan-maintains-overweight-on-kenvue-lowers-price-target-to-24

JP Morgan analyst Andrea Teixeira maintains Kenvue (NYSE:KVUE) with a Overweight and lowers the price target from $25 to $24.

 rbc-capital-maintains-outperform-on-kenvue-lowers-price-target-to-24

RBC Capital analyst Nik Modi maintains Kenvue (NYSE:KVUE) with a Outperform and lowers the price target from $25 to $24.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION